658 related articles for article (PubMed ID: 25695169)
21. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
[TBL] [Abstract][Full Text] [Related]
22. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
23. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
[TBL] [Abstract][Full Text] [Related]
24. Extraintestinal Clostridium difficile infections: a single-center experience.
Gupta A; Patel R; Baddour LM; Pardi DS; Khanna S
Mayo Clin Proc; 2014 Nov; 89(11):1525-36. PubMed ID: 25245597
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile outbreak strain BI is highly endemic in Chicago area hospitals.
Black SR; Weaver KN; Jones RC; Ritger KA; Petrella LA; Sambol SP; Vernon M; Burton S; Garcia-Houchins S; Weber SG; Lavin MA; Gerding D; Johnson S; Gerber SI
Infect Control Hosp Epidemiol; 2011 Sep; 32(9):897-902. PubMed ID: 21828970
[TBL] [Abstract][Full Text] [Related]
26. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
Messick CA; Hammel JP; Hull T
Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
[TBL] [Abstract][Full Text] [Related]
28. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
29. Rifaximin in the treatment of recurrent Clostridium difficile infection.
Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
[TBL] [Abstract][Full Text] [Related]
31. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
Catanzaro M; Cirone J
Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
[TBL] [Abstract][Full Text] [Related]
32. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
Li Y; Qian J; Queener E; Shen B
Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
[TBL] [Abstract][Full Text] [Related]
33. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital.
Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M
Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Multilocus Sequence Typing and the Xpert C. difficile/Epi Assay for Identification of Clostridium difficile 027/NAP1/BI.
McMillen T; Kamboj M; Babady NE
J Clin Microbiol; 2016 Mar; 54(3):775-8. PubMed ID: 26699700
[TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
37. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
[TBL] [Abstract][Full Text] [Related]
38. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
[TBL] [Abstract][Full Text] [Related]
39. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
Nurzyńska G; Pituch H; Kamola R; Kopeć ES
Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
